MRCT

MRC Technology is an independent life science medical research charity committed to drastically improving positive patient outcomes everywhere.

As a champion for human health, MRC Technology partners with academic, biotechnology, pharmaceutical, and charity organisations to move promising medical research forward into viable and accessible patient treatments.

Our people combine commercialisation and IP management skills with  diagnostic and drug discovery expertise, specialising in small molecule and therapeutic antibodies.

As a charity we are self funded, re-investing our incomes from developed drugs to support translating research from the bench to patient.

MRC Technology projects have led to the approved drugs Tysabri®,  Actemra®, Entyvio® and Keytruda®, changing the lives of countless patients by harnessing the potential of science.